Reversing FXa inhibitor activity in patients with acute major bleeding

Monday, May 22nd, 2023 | 11:00 AM - 12:00 PM CT

Every day, patients are hospitalized with a factor Xa (FXa) inhibitor-related acute major bleed. For those patients, every moment matters. Uncover the latest information on managing patients with FXa inhibitor-related acute major bleeding in this live discussion.

Learning Points:
 
  • The burden of life-threatening bleeds related to FXa Inhibitors
  • The rationale behind the reversal of anti-FXa activity
  • Clinical trials evaluating the efficacy and safety of FXa inhibitor reversal
  • Real world studies evaluating FXa inhibitor reversals 

Presenter: 

Paul Dobesh

Paul P. Dobesh, Pharm.D., FACC, FAHA, FCCP, BCPS, BCCP

Professor of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center